Mandate

Vinge advises Karl Hedin and minority owners on the sale of AB Karl Hedin Sågverk to Vida

July 24, 2025

Vinge has advised Karl Hedin and minority shareholders in connection with the sale of AB Karl Hedin Sågverk to Vida Aktiebolag (“Vida”).

Vida is a global supplier of processed products from Swedish forests. The Vida group has approximately 1,600 employees and sales of SEK 12 billion and conducts operations at 24 production facilities, including 12 sawmills. AB Karl Hedin Sågverk has three sawmills in Sweden and a well-established raw materials organisation in Bergslagen. The company has approximately 220 full-time employees and sales of SEK 1.8 billion. Following the acquisition, AB Karl Hedin Sågverk will continue to operate under its current name and trademark with Fredrik Marnefeldt as CEO.

Together Vida and AB Karl Hedin Sågverk will have a turnover of approximately SEK 14 billion, 1,800 employees and a sawmill production of 3.3 million cubic metres.

The transaction is subject to regulatory approvals.

Vinge’s team consisted mainly of Jonas Johansson, Johan Winnerblad, Egil Svensson and Olof Löfvenberg.

Read more in AB Karl Hedin's press release 

Related

Vinge advises Morrow Bank AB (publ) in connection with the bank’s sale of parts of MedMera Bank and the sale of NPL portfolios

Vinge has advised Morrow Bank AB (publ) in connection with the divestment of parts of MedMera Bank’s operations to a leading global credit investment firm. The divestment is structured as a sale of shares and priced at a premium of approximately SEK 90 million above equity value as per the completion date. The transaction includes parts of MedMera’s banking operations such as IT infrastructure, organisation and management, whilst Morrow Bank retains MedMera’s performing loans, deposits, customers, the MedMera brand, the Coop partnership agreement as well as key personnel.
September 15, 2026

Vinge advises HealthCap in conjunction with its investment in AMRA Medical

HealthCap is investing in AMRA Medical AB, a company that analyses whole-body MRI images to classify and quantify an individual’s muscle and fat tissue throughout the body and places this in relation to human health and disease.
September 15, 2026

Vinge has advised EQT managed Scaleup Europe Fund on its investment in Tandem Health

Vinge has advised EQT managed Scaleup Europe Fund as lead investor in Tandem Health's USD 100 million Series B investment round, with participation from existing investors Kinnevik, Northzone, Amino Collective and Visionaries. Tandem Health is an AI healthcare company founded in 2023 and headquartered in Sweden. Tandem Health operates as an AI partner within the healthcare sector across Europe, providing AI medical assistant support to clinicians in connection with patient visits.
September 15, 2026